Rimonabant

Mfr.No.	T1519L
Description	Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States.
Alternative Names	SR141716
Molecular Formula	C22H21Cl3N4O
Signaling Pathways	GPCR/G Protein, Metabolism, Microbiology/Virology
Smiles	CC1=C(N(N=C1C(NN2CCCCC2)=O)C3=C(Cl)C=C(Cl)C=C3)C4=CC=C(Cl)C=C4
Cas Number	168273-06-1
Molecular Weight	463.79
Target	Antibacterial, Acyltransferase, Cannabinoid Receptor

Have you used this product?

SKU	Supplier No.	Size	Your price
BHB20408287	T1519L	1 mL	$54	Add to Cart
BHB20408287	T1519L	10 mg	$42	Add to Cart
BHB20408287	T1519L	25 mg	$83	Add to Cart
BHB20408287	T1519L	50 mg	$132	Add to Cart
BHB20408287	T1519L	100 mg	$197	Add to Cart